5
Jun 2026
EULAR Congress highlights innovative support strategies for rheumatology patients
Rheumatic and musculoskeletal diseases (RMD) profoundly impact daily life, limiting both work ability and participation in everyday activities.
5
Jun 2026
Rheumatic and musculoskeletal diseases (RMD) profoundly impact daily life, limiting both work ability and participation in everyday activities.
5
Jun 2026
Announcing a new article publication in BIO Integration. Latent tuberculosis infection (LTBI) is difficult to diagnose due to the lack of a definitive gold standard.
5
Jun 2026
Randox Health today announces the launch of RanChip Insight 360, an advanced health intelligence programme designed to transform how individuals understand, monitor, and manage their long-term wellbeing.
5
Jun 2026
Idiopathic inflammatory myopathies (IIM) are a heterogenous group of autoimmune conditions with substantial morbidity.
5
Jun 2026
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular disease develops through gradual accumulation of risk factors and progressive vascular damage.
5
Jun 2026
"Politicians should be more open about the kind of healthcare services we can expect to receive", says a researcher who has studied patient complaints.
5
Jun 2026
An estimated 7.4 million Americans aged 65 and older are now living with Alzheimer's disease, according to the Alzheimer's Association's 2026 Alzheimer's Disease Facts and Figures report, and that number is projected to climb to nearly 13 million by 2050.
5
Jun 2026
Typical Norwegian drinking patterns can increase the risk of parents’ behavior negatively impacting their children.
5
Jun 2026
Lumo leverages advanced machine learning to reduce calibration time, and flag low-confidence response factor predictions.
5
Jun 2026
Research shows that combining resistance training with aerobic exercise significantly reduces mortality risk, emphasizing the importance of physical activity.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more